Lutetium (177Lu) chloride Billev is a solution containing a radioactive form of lutetium (177lu) that is used for radiolabelling other medicines. Radiolabelling is a technique where a substance is labelled with a radioactive compound. Once the substance is radiolabelled with Lutetium (177Lu) chloride Billev, it then carries the radioactivity to where it is needed in the body (for example, the site of a tumour). Lutetium (177Lu) chloride Billev is used to radiolabel medicines that have been specifically developed for use with lutetium (177lu) chloride. Lutetium (177Lu) chloride Billev contains the active substance lutetium (177lu) chloride.
Therapeutic Indication
### Therapeutic indication Lutetium (177Lu) chloride Billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. It is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177Lu) chloride.
Therapeutic Area (MeSH)
N/AATC Code
V10X
ATC Item
其它治疗用放射性药物
Pharmacotherapeutic Group
Therapeutic radiopharmaceuticals
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| lutetium (177Lu) chloride | N/A | Lutetium Lu-177 |
EMA Name
Lutetium (177Lu) chloride Billev (previously Illuzyce)
Medicine Name
Lutetium (177Lu) chloride Billev (previously Illuzyce)
Aliases
N/ANo risk management plan link.
